Medopad raises $25M led by Bayer to develop biomarkers tracked via apps and wearables – TechCrunch
Medopad, the UK startup that has been working with Tencent to develop AI-based methods for building and tracking “digital” biomarkers — measurable indicators of the progression of illnesses and diseases that are picked up not with blood samples or in-doctor v…
